Ownership history in RENAISSANCE TECHNOLOGIES LLC · 5 quarters on record
This page tracks every 13F SEC filing in which RENAISSANCE TECHNOLOGIES LLC reported a position in ENLIVEN THERAPEUTICS INC (ELVN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 59,000 | +35,100 | +146.9% | 0.00% | $1.2M | $20.47 |
| 2025 Q2 | ADDED | 23,900 | +12,000 | +100.8% | 0.00% | $479K | $20.06 |
| 2025 Q1 | REDUCED | 11,900 | -24,250 | -67.1% | 0.00% | $234K | $19.68 |
| 2023 Q2 | REDUCED | 36,150 | -34,108 | -48.5% | 0.00% | $738K | $20.41 |
| 2023 Q1 | INITIATED | 70,258 | — | — | 0.00% | $1.5M | $21.90 |
As of 2025 Q4 — sorted by position size